BEN STANSALL/AFP/Getty Images
The headquarters of the British pharmaceutical company GlaxoSmithKline is pictured in west London on July 29, 2013.
In what appears to be a first, the British drug company GlaxoSmithKline said it will stop paying doctors to promote its products.
CEO Andrew Witty released a statement yesterday. In it he noted the company aims "To bring greater clarity and confidence that whenever we talk to a doctor, nurse or other prescriber, it is in the patients' interests that always come first."
For more on the significance of the announcement, we turn to the New York Times Katie Thomas.